Skip to main content
Clinical Trials/CTRI/2012/12/003173
CTRI/2012/12/003173
Completed
未知

Evaluation of dermatological safety of investigational products by primary irritation patch test on healthy volunteers of varied skin types.

ITC RD Centre0 sites24 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ITC RD Centre
Enrollment
24
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ITC RD Centre

Eligibility Criteria

Inclusion Criteria

  • Subjects age group 18 \- 55 years
  • Healthy male \& female volunteers
  • Subjects with skin type III to V.
  • Subjects willing to give a written informed consent.
  • Subjects willing to maintain the patch test in position for 24 hours
  • Subject has not participated in a similar investigation in the past two weeks.
  • Subjects willing to come for regular follow up.
  • Subjects ready to follow instructions during the study period.

Exclusion Criteria

  • Infection, allergy on the tested area
  • Skin allergy antecedents or atopic subjects
  • Hyper sensitivity to any component of the tested products
  • Athletes and subjects with history of excessive sweating
  • Cutaneous disease which may influence the study result
  • Chronic illness which may influence the cutaneous state.
  • Subjects on oral corticosteroid with dose 10mg/day
  • Subjects participating in any other cosmetic or therapeutic trial.
  • Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials